CLOV
Income statement / Annual
Last year (2024), Clover Health Investments, Corp.'s total revenue was $1.37 B,
an increase of 8.77% from the previous year.
In 2024, Clover Health Investments, Corp.'s net income was -$43.01 M.
See Clover Health Investments, Corp.,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2024
|
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
| Period Ended |
12/31/2024 |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
12/31/2018 |
| Operating Revenue |
$1.37 B |
$1.26 B |
$1.10 B |
$1.47 B |
$672.89 M |
$462.27 M |
$281.02 M |
| Cost of Revenue |
$1.01 B
|
$1.00 B
|
$993.07 M
|
$1.55 B
|
$590.08 M
|
$449.70 M
|
$0.00
|
| Gross Profit |
$364.80 M
|
$255.95 M
|
$103.48 M
|
-$79.18 M
|
$82.81 M
|
$12.57 M
|
$281.02 M
|
| Gross Profit Ratio |
0.27
|
0.2
|
0.09
|
-0.05
|
0.12
|
0.03
|
1
|
| Research and Development Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| General & Administrative Expenses |
$408.93 M
|
$440.25 M
|
$482.40 M
|
$445.75 M
|
$192.09 M
|
$187.33 M
|
$103.04 M
|
| Selling & Marketing Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$84.24 M
|
| Selling, General & Administrative Expenses |
$408.93 M
|
$440.25 M
|
$482.40 M
|
$445.75 M
|
$192.09 M
|
$187.33 M
|
$187.28 M
|
| Other Expenses |
$1.62 M
|
$21.04 M
|
-$92.26 M
|
$112.07 M
|
-$16.57 M
|
$8.44 M
|
$0.00
|
| Operating Expenses |
$410.55 M
|
$461.28 M
|
$390.14 M
|
$557.81 M
|
$175.51 M
|
$195.76 M
|
$476.00 M
|
| Cost And Expenses |
$1.42 B
|
$1.47 B
|
$1.38 B
|
$2.11 B
|
$765.60 M
|
$645.47 M
|
$476.00 M
|
| Interest Income |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$117,255.00
|
$0.00
|
$6.95 M
|
| Interest Expense |
$0.00
|
$7,000.00
|
$1.36 M
|
$16.91 M
|
$57.11 M
|
$39.07 M
|
$0.00
|
| Depreciation & Amortization |
$1.33 M
|
$2.51 M
|
$1.19 M
|
$1.25 M
|
$555,000.00
|
$551,000.00
|
$185.80 M
|
| EBITDA |
-$44.94 M |
-$207.63 M |
-$252.03 M |
-$569.60 M |
-$78.73 M |
-$324.12 M |
-$16.13 M |
| EBITDA Ratio |
-0.03
|
-0.16
|
-0.23
|
-0.39
|
-0.12
|
-0.7
|
-0.06
|
| Operating Income Ratio |
-0.03
|
-0.16
|
-0.26
|
-0.43
|
-0.14
|
-0.4
|
-0.66
|
| Total Other Income/Expenses Net |
-$517,000.00
|
-$4.82 M
|
$32.08 M
|
$49.24 M
|
-$43.69 M
|
-$180.54 M
|
-$16.13 M
|
| Income Before Tax |
-$46.27 M
|
-$210.15 M
|
-$254.58 M
|
-$587.76 M
|
-$136.39 M
|
-$363.74 M
|
-$201.93 M
|
| Income Before Tax Ratio |
-0.03
|
-0.17
|
-0.23
|
-0.4
|
-0.2
|
-0.79
|
-0.72
|
| Income Tax Expense |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
-$16.13 M
|
| Net Income |
-$43.01 M
|
-$213.36 M
|
-$339.57 M
|
-$587.76 M
|
-$136.39 M
|
-$363.74 M
|
-$201.93 M
|
| Net Income Ratio |
-0.03
|
-0.17
|
-0.31
|
-0.4
|
-0.2
|
-0.79
|
-0.72
|
| EPS |
-0.08 |
-0.45 |
-0.71 |
-1.25 |
-0.23 |
-0.9 |
-4.81 |
| EPS Diluted |
-0.08 |
-0.45 |
-0.71 |
-1.25 |
-0.23 |
-0.9 |
-4.81 |
| Weighted Average Shares Out |
$490.02 M
|
$482.18 M
|
$476.24 M
|
$470.85 M
|
$404.44 M
|
$404.44 M
|
$42.01 M
|
| Weighted Average Shares Out Diluted |
$490.02 M
|
$482.18 M
|
$476.24 M
|
$470.85 M
|
$404.44 M
|
$404.44 M
|
$42.01 M
|
| Link |
|
|
|
|
|
|
|
